参考文献/References:
[1] Li XY,Tang JT,Mao YM.Incidence and risk factors of drug-induced liver injury[J].Liver Int,2022,42(9):1999-2014.
[2] Yonezuka Y,Kuwada H,Imaishi H.Diagnosis of drug-induced liver injury in model mice by studying the inhibitory effect of serum components on P450 inhibition assay[J].Chem Biol Interact,2022,365:110075.
[3] Heldring MM,Shaw AH,Beltman JB.Unraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury[J].NPJ Syst Biol Appl,2022,8:27.
[4] Moreno TM,Quintás G,Castell JV.The potential role of metabolomics in drug-induced liver injury(DILI)assessment[J].Metabolites,2022,12(6):564.
[5] Shen T,Liu YX,Shang J,et al.Incidence and etiology of drug-induced liver injury in mainland China[J].Gastroenterology,2019,156:2230-2241.
[6] Long A,Magrath M,Mihalopoulos M,et al.Changes in epidemiology of acetaminophen overdoses in an urban county hospital after 20 years[J].Am J Gastroenterol,2022,117:1324-1328.
[7] 刘应莉,王艳荣,张秋瓒.肠道菌群-过氧化物酶体增殖物激活受体信号通路及其在代谢相关脂肪性肝病发病中的作用研究进展[J].陕西医学杂志,2021,50(9):1166-1168.
[8] 胡锦华,娄月芬.药物性肝损伤发病机制与诊疗的研究进展[J].上海医学,2020,43(11):699-704.
[9] Li M,Luo Q,Tao YY,et al.Pharmacotherapies for drug-induced liver injury:A current literature review[J].Front Pharmacol,2021,12:806249.
[10] Licata A,Minissale M,Giovanna,SS,et al.N-acetylcysteine for preventing acetaminophen-induced liver injury:A comprehensive review[J].Front Pharmacol,2022,13:828565.
[11] Peng Y,Zhu GR,Ma YY,et al.Network pharmacology-based prediction and pharmacological validation of effects of astragali radix on acetaminophen-induced liver injury[J].Front Med(Lausanne),2022,9:697644.
[12] 陈俐秀,蒋璐慧,卢顺玉,等.柿寄生提取物对对乙酰氨基酚诱导小鼠肝损伤的保护作用及作用机制[J].中国医院药学杂志,2019,39(14):1435-1438.
[13] 艾丁丁,罗伟生,蒋云霞.动物肝纤维化模型建立研究进展[J].陕西医学杂志,2020,49(7):907-909.
[14] 吴佳栩,江 锋,薛 婧.中医药治疗药物性肝损伤的现状与思考[J].中西医结合肝病杂志,2021,31(12):1119-1122.
[15] 黄祖鸿,石清兰,柏文婕,等.毛德文教授运用“调肝理脾”法治疗慢性肝病经验总结[J].陕西中医,2021,42(8):1112-1114,1119.
[16] 雷 玲,闵 珺,刘 锋,等.黄芪对肝纤维化大鼠肝损伤保护作用及机制研究[J].陕西中医,2020,41(9):1192-1196.
[17] Bjornsson ES,Vucic V,Stirnimann G,et al.Role of corticosteroids in drug-induced liver injury:A systematic review[J].Front Pharmacol,2022,13:820724.
[18] Jiang XL,Luo PY,Zhou YY,et al.Oplopanax elatus hepatoprotective effect of nakai adventitious roots extract by regulating CYP450 and PPAR signaling pathway[J].Front Pharmacol,2022,13:761618.
[19] Wang L,Zhang LY,Wang JY,et al.Protective effect of dandelion leaf water extracts on APAP-induced liver injury in rats and its mechanism[J].Cell Mol Biol(Noisy-le-grand),2022,68:24-33.
[20] Guo HT,Xie MJ,Liu WX,et al.Inhibition of BTK improved APAP-induced liver injury via suppressing proinflammatory macrophages activation by restoring mitochondrion function[J].Int Immunopharmacol,2022,110:109036.
[21] Jiang ZT,Yang X,Han Y,et al.Sarmentosin promotes USP17 and regulates Nrf2-mediated mitophagy and cellular oxidative stress to alleviate APAP-induced acute liver failure[J].Phytomedicine,2022,104:154337.
[22] Wang JC,Zhang LL,Shi Q,et al.Targeting innate immune responses to attenuate acetaminophen-induced hepatotoxicity[J].Biochem Pharmacol,2022,202:115142.
[23] 唐文诚,何 清.枳椇水提物对对乙酰氨基酚致小鼠急性肝损伤的相关机制研究[J].药物分析杂志,2021,41(2):245-251.